ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions

Core Insights - ICON plc, a leading clinical research organization, released results from a survey highlighting challenges faced by clinical trial sites during study startup [1] - The survey emphasizes the necessity for a site-centric and collaborative approach to address bottlenecks and improve trial activation timelines [1] Survey Details - The survey was conducted in June 2025 and included responses from over 100 principal investigators and senior clinical trial site personnel [1] - Findings indicate significant operational challenges that require strategic solutions to enhance efficiency in clinical trials [1]